ID
42317
Descrição
Study ID: 108708 Clinical Study ID: 108708 Study Title: A phase IIb, controlled, randomized, multicentre, observer blinded study to evaluate the immunogenicity, safety and reactogenicity of a second vaccination with the low dose influenza vaccine adjuvanted with AS03 compared to a second dose of FluarixTM (GlaxoSmithKline Biologicals) administered intramuscularly in elderly >= 60 years previously vaccinated in FLU-LD-002 clinical trial Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00385840 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Influenza Vaccine GSK1247446A Trade Name: FluarixTM Study Indication: Influenza
Palavras-chave
Versões (1)
- 29/05/2021 29/05/2021 -
Titular dos direitos
GlaxoSmithKline
Transferido a
29 de maio de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Immunogenicity, safety and reactogenicity of a second vaccination with the low dose influenza vaccine adjuvanted with AS03 NCT00385840
Visit 1, Day 0 Vaccination: Informed Consent; Demographics; Randomisation
Similar models
Visit 1, Day 0 Vaccination: Informed Consent; Demographics; Randomisation
C0019994 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0019994 (UMLS CUI [1,2])
C1522541 (UMLS CUI-2)
C0600091 (UMLS CUI [1,2])